Clinical Trials Browser

Phase 1 × NIH × Fibrosis × Clear all

NCT02143401 2024-11-22

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

Phase 1 Completed

Gastrointestinal

Fibrosis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms

NCT03278925 2024-08-02

Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis

Phase 1 Active not recruiting

Fibrosis